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Abstract
Enteropathogenic and enterohemorrhagic bacterial infections in humans are a severe cause of morbidity and mortality.
Although NOD-like receptors (NLRs) NOD2 and NLRP3 have important roles in the generation of protective immune
responses to enteric pathogens, whether there is crosstalk among NLRs to regulate immune signaling is not known. Here,
we show that mice and macrophages deficient in NOD2, or the downstream adaptor RIP2, have enhanced NLRP3- and
caspases-11-dependent non-canonical inflammasome activation in a mouse model of enteropathogenic Citrobacter
rodentium infection. Mechanistically, NOD2 and RIP2 regulate reactive oxygen species (ROS) production. Increased ROS in
Rip2-deficient macrophages subsequently enhances c-Jun N-terminal kinase (JNK) signaling resulting in increased caspase-
11 expression and activation, and more non-canonical NLRP3-dependant inflammasome activation. Intriguingly, this leads
to protection of the colon epithelium for up to 10 days in Rip2-deficient mice infected with C. rodentium. Our findings
designate NOD2 and RIP2 as key regulators of cellular ROS homeostasis and demonstrate for the first time that ROS
regulates caspase-11 expression and non-canonical NLRP3 inflammasome activation through the JNK pathway.
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Introduction
Enteropathogenic and enterohemorrhagic Escherichia coli
(EPEC and EHEC) infections in humans are a major source of
morbidity and mortality, especially in developing countries [1]. To
study these infections, Citrobacter rodentium is used as an enteric
bacterial pathogen of mice that triggers similar inflammatory
responses to those observed in humans infected with EPEC and
EHEC [2]. As with EPEC and EHEC in humans, C. rodentium
infection in the mouse results in bacterial attachment and effacing
lesion formation in the lumen of the colon [3]. Clearance of C.
rodentium from the host tissues requires contributions from
humoral and Th1 immune responses [4–6]. However, innate
immunity is also important for early bacterial control [7,8] and for
the initiation of adaptive immunity [9,10].
Innate immunity to pathogens depends on a limited set of germ-
line encoded pattern recognition receptors (PRRs) that sense
conserved pathogen motifs. Innate receptors initiate inflammation
through activation of pro-inflammatory transcription factors such
as NF-kB, by promoting activation of proinflammatory caspases in
inflammasomes, and by initiating programmed cell death of
infected cells. The intracellular NOD-like receptors (NLRs)
NOD1 and NOD2 recognize peptidoglycan fragments from
bacterial cell walls in the cytosol, which results in pro-inflamma-
tory NF-kB and MAP-kinase pathway activation via the adaptor
RIP2 [11–13]. However, pathogen infection is frequently accom-
panied by ion fluxes and vacuolar membrane damage elicited by
the action of microbial toxins and effectors of specialized bacterial
secretion systems [14–17]. Thus, while conserved bacterial
peptidoglycan fragments are initially recognized by receptors
NOD1 and NOD2, the perturbations inflicted over the course of
infection can activate NLRP3.
NLRP3 is the most studied inflammasome-associated NLR.
Signaling events initiated by Toll-like receptors (TLRs) contribute to
NF-kB mediated up-regulation of NLRP3 and pro-IL-1b for robust
activation [18]. No specific pathogen-derived ligand is known to bind
and activate NLRP3. Instead, NLRP3 is activated in response to
diverse stimuli including microbial, environmental and metabolic
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perturbations, which culminate in the generation of reactive oxygen
species, changes in ion flux or leakage of cathepsin B into the cytoplasm
[19–21]. These cellular damage signals induce NLRP3 to form an
inflammasome complex with the adaptor ASC and the cysteine
protease caspase-1 that enables the maturation of IL-1b and IL-18
cytokines and pyroptotic cell death [22–25]. An alternative non-
canonical pathway of NLRP3 activation that additionally involves
upstream caspase-11 activation has been described in response to
cytosolic LPS and gram-negative enteric pathogens such as Citrobacter
rodentium and Escherichia coli [26,27]. Recent studies have extended
the requirement of the non-canonical inflammasome to other gram-
negative pathogens such as flagellin-deficient Legionella pneumophila
(DflaA) [28] and Salmonella typhimurium (Dfljb/flic) [29]. Studies
from our lab and others suggest that activation of the non-canonical
NLRP3 inflammasome requires TLR4-TRIF mediated type-I inter-
feron dependent production of caspase-11 [30,31]. However, whether
NLR signaling pathways can regulate the non-canonical NLRP3
inflammasome is not known. Here, we show that activation of the
cytoplasmic NOD2-RIP2 pathway modulates caspases-11 expression
and activation of the non-canonical inflammasome in response to C.
rodentium and Dfljb/flic Salmonella typhimurium infection.
Results
Nod2- and Rip2-deficient cells display enhanced
inflammasome activation
Signaling events initiated by TLRs contribute to NF-kB mediated
up-regulation of NLRP3 and pro-IL-1b [18]. However, whether
TLR or NLR pathways can restrain or negatively regulate
inflammasome activation is not known. To examine the role of
NOD2 in inflammasome activation, WT andNod22/2 bone marrow
derived macrophages (BMDM) were infected with C. rodentium and
caspase-1 activation was analyzed at 18 h post-infection. Nod2-
deficient cells exhibited increased caspase-1 activation and this was
accompanied with elevated production of IL-18 (Figure 1A–C).
Similarly, Rip22/2 cells displayed increased caspase-1 activation and
IL-18 secretion (Figure 1D–F). Furthermore, increased caspase-1
activation was not due to increased bacterial loads becauseNod22/2
and Rip22/2 macrophages exhibited comparable C. rodentium
uptake and clearance (Fig. 1G). These results suggest that the
NOD2-RIP2 axis negatively regulates inflammasome activation to C.
rodentium infection.
The NOD2-RIP2 axis specifically restricts the NLRP3
inflammasome
Activation of caspase-1 is triggered downstream of several NLRs
including NLRP3, NLRP1 and NLRC4 [23,32,33]. Previously, we
have shown that infection with C. rodentium specifically activates
the non-canonical NLRP3 inflammasome [30]. To determine the
extent of NOD2-RIP2 modulation, we examined whether this
pathway also modulates the NLRC4 inflammasome. To answer
this, we infected WT, Nod2- and Rip2-deficient cells with
Salmonella typhimurium to activate the NLRC4-inflammasome.
However, comparable caspase-1 activation was observed in S.
typhimurium infected WT, Nod22/2 and Rip22/2 cells (Figur-
e 2A,B). In agreement, IL-18 levels were similar (Figure 2C)
suggesting that the NOD2-RIP2 pathway specifically restricts the
NLRP3 inflammasome. The NLRC4 inflammasome is activated
upon recognition of S. typhimurium flagellin [34,35]. However,
flagellin-deficient S. typhimurium Dfljb/flic activates the NLRP3
inflammasome [29]. Consequently, Nod22/2 or Rip22/2 BMDM
infected with the S. typhimurium Dfljb/flic strain displayed
enhanced caspase-1 activation and IL-18 production over wildtype
BMDM (Figure 2D–F). These results suggest that NOD2 and
RIP2 specifically modulated the NLRP3 inflammasome in this
model while the NLRC4 inflammasome was not affected by the
absence of the NOD2-RIP2 signaling axis.
Glyburide, a type 2 diabetes drug, has been shown to
specifically inhibit the NLRP3 inflammasome in response to
microbial and crystalline stimuli [36]. To further verify that the
enhanced caspase-1 activation observed in Nod2- and Rip2-
deficient BMDM is the result of elevated NLRP3 inflammasome
activation, we exposed Rip2-deficient BMDM to glyburide
following C. rodentium infection. Consistent with the requirement
for NLRP3, we observed increased caspase-1 activation in Rip2-
deficient cells and this was markedly abrogated in the presence of
glyburide (Figure 2G,H). In agreement, enhanced IL-18 levels in
Rip22/2 BMDM were significantly decreased upon treatment
with glyburide (Figure 2I). In contrast, glyburide treatment did
not affect caspase-1 activation in Rip2-deficient cells infected with
S. typhimurium (Figure 2J,K). Consequently, IL-18 levels were
also unaffected (Figure 2L). These data indicate that NOD2-
RIP2 signaling specifically modulates NLRP3 activation and does
not regulate all inflammasomes.
Rip2-deficient cells show increased ROS production
To determine the cause of increased NLRP3 inflammasome
activation during C. rodentium infection, we examined the
possibility that there is a global dysregulation of cytokines and
inflammation in Rip2-deficient BMDM. However, there was no
difference in IL-6 production and TNF-a levels were lower in
Rip2-deficient cells (Figure 3A) suggesting that a global increase
in inflammation is not responsible for increased NLRP3 inflam-
masome activation in this model.
Elevated production of reactive oxygen species (ROS) has
previously been associated with increased NLRP3 inflammasome
activation [37]. In particular, mitochondrial-derived ROS pro-
duction was suggested to provoke NLRP3 activation [38], and we
previously demonstrated that Rip2-deficient cells have defects in
autophagy that lead to the accumulation of damaged mitochon-
dria [39]. LC3 is an autophagy-associated protein that is localized
in the cytosol under steady state conditions, but relocalizes to
autophagosome membranes when autophagy occurs [40]. During
C. rodentium infection of WT or Rip22/2 BMDM, the number of
autophagosomes was examined using confocal microscopy by
counting GFP-LC3+ puncta per cell (Figure 3B–C). Alternative-
ly, we used flow cytometry to measure the fluorescence intensity of
GFP-LC3 after permeablizing cells so that only autophagosome
membrane bound GFP-LC3 remained (Figure 3D). In both
cases, we found that autophagy was impaired in Rip22/2 BMDM
compared to WT cells after C. rodentium infection. Furthermore,
Rip2-deficient BMDM exhibited elevated levels of mitochondria-
Author Summary
Caspase-11 is required for NLRP3 inflammasome activation
and cell death in response to certain gram-negative
bacterial infections like Citrobacter rodentium. However,
how C. rodentium drives caspase-11 expression and
activation is not well understood. Here, we demonstrate
that the NOD2-RIP2 pathway regulates reactive oxygen
species production and c-Jun N-terminal kinase signaling
to control caspase-11 expression and subsequent activa-
tion of caspase-11 and the NLRP3 inflammasome during C.
rodentium infection. In the absence of NOD2-RIP2 signal-
ing, increased inflammasome activation results in lower
bacteria numbers in the colon and less tissue damage
during the early stages of infection.
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derived superoxide when infected with C. rodentium and stained
with the mitochondrial specific ROS sensor MitoSOX (Figur-
e 3E,F). Finally, Rip22/2 BMDM treated with the ROS
scavenger N-acetyl-L-cysteine (NAC) had reduced caspase-1
activation and IL-18 production compared to WT cells (Fig-
ure 3G–I). Thus, the presence of dysfunctional mitochondria in
Figure 1. Enhanced inflammasome activation in Nod22/2 and Rip22/2 BMDMs. BMDM were generated from WT, Nod22/2 and Rip22/2 mice
and infected with 20MOI of Citrobacter rodentium for 18 h. (A–F) Combined supernatant and lysates were examined by Western blot for caspase-1
cleavage (casp-1p20) visually (A,D) and by densitometry (B,E), or (C,F) supernatants were examined for IL-18 secretion by ELISA. (G) BMDM were
infected with C. rodentium and assayed for intracellular growth at the indicated times post-infection. (A–F) Data are representative of five
independent experiments with n = 2–3 wells per experiment. (G) Data are representative of two independent experiments with n = 2–3 wells per
experiment. (B,C,E,F,G) Data are shown as the mean 6 SEM. (*, p,0.05; **, p,0.01; ***, p,0.001).
doi:10.1371/journal.ppat.1004410.g001
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Rip22/2 cells leads to enhanced ROS production and thereby
increased NLRP3 inflammasome activation.
Caspase-11 activation is upregulated in Rip2-deficient
cells
Enteric pathogens such as C. rodentium are known to activate the
NLRP3 inflammasome by a non-canonical pathway, which
additionally requires caspase-11 for its activation [26]. We therefore
postulated that during C. rodentium infection increased ROS
production might act upstream of caspase-11 as well as caspase-1.
Therefore, we sought to examine the role of caspase-11 in the
present study. First, we determined that activation of caspase-11 is
enhanced in Rip22/2 BMDM (Fig. 4A,B). Next, we treated
Rip22/2 BMDM with the ROS scavenger NAC following C.
rodentium infection and observed that caspase-11 activation was
significantly diminished compared to mock-treated Rip22/2
BMDM controls (Figure 4C,D). We also found that caspase-11
activation (p30 band) correlated with the expression of p43/p38
(pro-caspase-11). Indeed, densitometric analysis showed that C.
rodentium infected Rip22/2 BMDM had higher expression of pro-
caspase-11 and that treatment with NAC inhibited pro-caspase-11
expression (Figure 4E). Mechanistically, we examined whether the
increased caspase-11 seen in Rip22/2 BMDM was the result of
defects in protein turnover; however, treatment ofWT andRip22/2
BMDM 4 h after infection with the proteasome inhibitor MG-132
resulted in accumulation of caspase-11 in both WT and Rip22/2
BMDM (Figure 4F–G). Instead, Casp11 mRNA was higher in
Rip22/2 BMDM compared to WT BMDM (Figure 4H). These
results indicate that RIP2 regulates caspase-11 at the level of mRNA
expression, possibly through enhanced ROS production.
Exogenous ROS enhances caspase-11 expression and
activation in WT cells
To further confirm the role of enhanced ROS production
leading to increased inflammasome activation in Rip22/2
BMDM, we examined the effects of treating WT BMDM with
exogenous ROS. WT BMDM were infected with C. rodentium
and treated with H2O2 as a ROS source 6 h after infection.
Although H2O2 treatment had no effect on Il18 mRNA levels
following C. rodentium infection, we detected significantly more
IL-18 in the culture medium (Figure 5A,B). In agreement,
caspase-1 activation was also increased following H2O2 treatment
(Figure 5C). Importantly, H2O2 treatment of WT cells resulted in
increased mRNA and protein expression of caspase-11 by qRT-
PCR and Western blot respectively (Figure 5D–F). Our results
indicate that ROS produced during C. rodentium infection can
enhance caspase-11 expression and subsequently potentiate
activation of the non-canonical inflammasome.
ROS regulates caspases-11 through a JNK mediated
pathway
Our data indicate that ROS is capable of regulating caspase-11
expression. However, it remains unclear what pathways are
regulated by ROS that subsequently affect caspase-11 expression.
As a TLR4-TRIF-IFN-b pathway has been established for
expression of caspase-11 [30,31], we examined the level of type-
I interferons, but found they were similar between WT, Rip22/2,
and Nod22/2 BMDM (Figure 6A). One pathway that is
responsive to ROS is the c-Jun N-terminal kinase (JNK) pathway
[41]. We next infected WT BMDM with C. rodentium, treated
them with H2O2 and examined the effects on JNK1/2 phosphor-
ylation. H2O2 treatment resulted in increased JNK phosphoryla-
tion compared to mock treated cells (Figure 6B). Similarly,
Rip22/2 BMDM infected with C. rodentium alone had substan-
tially more JNK1/2 phosphorylation than WT cells (Figure 6C).
Finally, we infected WT or Rip22/2 BMDM with C. rodentium
and then treated Rip22/2 BMDM with the JNK inhibitor
SP600125. We observed that caspase-11 levels were reduced in
conjunction with reduced JNK1/2 activation (Figure 6D). From
these results we propose that in the absence of NOD2-RIP2
signaling, defective autophagy results in the accumulation of ROS
and the subsequent enhancement of JNK signaling. This
ultimately leads to an increase in caspase-11 expression and
non-canonical inflammasome activation (Figure 6E).
Increased non-canonical inflammasome activation
provides protection against C. rodentium induced colitis
To determine the physiological relevance of our proposed
pathway, we examined Rip2-deficient mice for IL-18 production
and inflammasome activation in the colon during C. rodentium
induced colitis. On day 10 post-infection, caspase-11 and caspase-
1 activation were much higher in colon lysates of Rip22/2 mice
compared to WT controls (Figure 7A,B). IL-18 activation was
significantly increased by Western blot and IL-18 levels were
higher in colon lysates taken from Rip22/2 mice compared to WT
controls (Figure 7C,D). In contrast, bacterial loads in the colon
were reduced in Rip22/2 versus WT mice (Figure 7E). In
agreement, colon tissue examined on day 10 after infection
showed increased numbers of bacteria adherent to the mucosal
surface in WT compared to Rip22/2 mice (Figure 7F). Intrigu-
ingly, colon sections from WT mice also showed more hyperplasia
and inflammation and the extent of colon area that was inflamed
was more pronounced with WT mice compared to Rip22/2 mice
(Figure 7F,G). The stool of Rip22/2 mice also had fewer C.
rodentium CFU at both day 7 and day 10, highlighting the
protective effect of increased inflammasome activation during the
innate immune phase of infection (Figure 7H). These results
demonstrate that the NOD2-RIP2 pathway plays an important
role in regulating the non-canonical NLRP3 inflammasome in
vivo during C. rodentium-induced colitis. Of note, previous reports
have demonstrated an essential role for adaptive immunity in the
eventual clearance of C. rodentium [9,42]. In agreement with these
studies, on day 14 after infection, mice deficient in RIP2 signaling
had a clearance defect in the stool (Figure 7H). Finally, to verify
that increased inflammasome activation and IL-18 production
were responsible for the lower bacterial numbers on day 7 or 10,
we infected WT, Rip22/2, and Rip22/26Il182/2 mice with C.
Figure 2. NOD2 and RIP2 specifically regulate NLRP3 inflammasome activation. (A–B) WT, Nod22/2 and Rip22/2 BMDM were infected
with 1MOI Salmonella typhimurium for 4 h and combined supernatant and lysates were examined by Western blot for caspase-1 cleavage (casp-1p20)
visually (A) and by densitometry (B). (C) Supernatants were examined 4 h after S. typhimurium infection for IL-18 secretion. (D–F) WT, Nod22/2 and
Rip22/2 BMDM were infected with 10MOI S typhimurium Dfljb/flic mutant for 18 h. Caspase-1 activation and IL-18 were examined as in panels A–C.
(G–I) WT and Rip22/2 BMDM were infected with 20MOI of C. rodentium for 2 h and Rip22/2 cells were subsequently treated with the NLRP3 specific
inhibitor glyburide or mock treated as a control. Caspase-1 activation and IL-18 were examined as in panels A–C. (J–L) WT and Rip22/2 BMDM were
infected with 1MOI of S. typhimurium and Rip22/2 cells were simultaneously treated with the NLRP3 specific inhibitor glyburide or mock treated as a
control. Caspase-1 activation and IL-18 were examined as in panels A–C. (A–L) Data are representative of three independent experiments with n = 2–3
wells per experiment and displayed as the mean 6 SEM. (*, p,0.05; **, p,0.01; ***, p,0.001).
doi:10.1371/journal.ppat.1004410.g002
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rodentium and examined bacterial loads on day 7 after infection.
As before, Rip22/2 mice had significantly lower bacterial
numbers compared to WT mice. However, the deletion of IL-18 in
Rip22/26Il182/2 mice resulted in significantly increased bacterial
burden compared to the Rip22/2 mice (Figure 7I).
Discussion
Regulation of the non-canonical NLRP3 inflammasome is still
not well understood. It is clear that pathogen entry into the cytosol
is required for caspase-11 activation [17,43,44]. In addition,
caspase-11 activation requires guanylate binding protein (GBP) for
activation in response to cytosolic LPS [45]. However, the exact
upstream LPS sensor has yet to be identified [46,47]. Although the
exact activation mechanism involved is not clear, our lab and
others demonstrated that expression of caspase-11 via a TLR4-
TRIF-IFN-b-dependent mechanism is necessary for non-canoni-
cal NLRP3 inflammasome activation during C. rodentium
infection [30,31]. Our current findings show that ROS produced
during C. rodentium infection, or added exogenously to infected
cells as H2O2, is capable of regulating caspase-11 expression. In
agreement, treatment with the ROS scavenger NAC dampened
caspase-11 expression and activation, and subsequently reduced
caspase-1 activation through the non-canonical NLRP3 inflam-
masome. Mechanistically, Rip22/2 cells display enhanced ROS
production following C. rodentium infection, and our data define a
pathway where ROS acts through JNK signaling to increase
caspase-11 expression and the subsequent activation of the non-
canonical NLRP3 inflammasome.
Similar to C. rodentium, we found that infection with flagellin-
deficient S. typhimurium Dfljb/flic resulted in augmented inflam-
masome activation in Nod22/2 and Rip22/2 BMDM. Since
activation of the NLRC4 inflammasome was comparable between
WT and Rip2-deficient BMDM infected with WT S. typhimur-
ium, these data suggest that NOD2-RIP2 mediated regulation of
ROS and JNK activation specifically modulates the non-canonical
NLRP3 inflammasome and not NLRC4.
In addition to the mechanistic insight provided by our in vitro
studies, caspase-1 activation has never been examined in Rip22/2
mice in response to C. rodentium. Our findings demonstrate the
NOD2-RIP2 pathway helps suppress the non-canonical NLRP3
inflammasome in vivo during C. rodentium induced colitis. In the
absence of RIP2, there is increased caspase-11 and caspase-1
activation and higher levels of processed IL-18. These increases
are associated with reduced bacterial burden and protection of the
colon epithelium during the innate immune phase of infection (d7–
d10). Our findings are thus in line with our previous publications,
which show that NLRP3 inflammasome activation and IL-18
production are important for the control of bacterial burden and
disease during C. rodentium infection [48]. The importance of IL-
18 in the protection seen in this model was also confirmed through
the use of Rip22/26Il182/2 mice. Although IL-18 deletion in
Rip22/2 mice did not entirely abolish the protective phenotype,
this is likely due to pyroptosis or other functions of caspase-11,
such as lysosome-phagosome fusion [49].
Other reports have examined NOD2 signaling in vivo.
However, these reports focused on the effects of NOD2-RIP2
signaling on the adaptive immune response. Intriguingly, similar
results to ours were published for the ubiquitin ligase pellino3,
which is required for NOD2-RIP2 signaling. At early time points,
Peli32/2 mice had reduced bacterial burden similar to our model,
but after d14, these mice showed a clearance defect [42]. On the
other hand, Nod22/2 mice displayed reduced production of the
chemokine CCL2, which ultimately lead to impaired adaptive
immunity and impaired clearance of C. rodentium after d14 of
infection [9]. Collectively, these findings suggest that increased
NLRP3 inflammasome activation provides protection early during
the innate immune phase, but the defects in adaptive immunity
that are also present in Nod22/2, Rip22/2, or Peli32/2 mice
ultimately lead to an inability of these mice to resolve the infection.
Although inflammation and cell death are important for
bacterial clearance [25], they also increase the likelihood of
bacterial dissemination to other tissues and induction of severe
inflammatory responses by increased tissue damage and released
cellular contents [50–52]. Therefore, the sequential and carefully
orchestrated activation of inflammatory pathways is essential for
pathogen clearance as well as maintaining homeostasis in the host.
Initial recognition of specific peptidoglycan fragments from
bacterial cell walls by the NOD2-RIP2 pathway, results in pro-
inflammatory NF-kB and MAP-kinase activation within minutes
of infection [53,54]. However, if this initial inflammatory burst is
inadequate, then subsequent inflammatory pathways, such as the
non-canonical NLRP3 inflammasome, are initiated. One common
feature of pathogens that activate the non-canonical NLRP3
inflammasome is activation proceeds with slower kinetics than
during canonical activation. In all instances, non-canonical
NLRP3 inflammasome activation is observed only after a time-
period of 12 to 16 h [26,28,30,31], whereas canonical activation
requires less than 1 h [21,22,55]. Based on our results, we propose
that NOD2-RIP2 signaling initially suppresses or delays non-
canonical NLRP3 inflammasome activation by preventing or
removing mitochondrial damage. However, extended assault from
C. rodentium eventually overcomes these mechanisms and leads to
ROS generation and activation of the non-canonical NLRP3
inflammasome [20,39,56]. In the absence of NOD2 or RIP2,
increased mitochondrial damage and ROS production leads to
elevated JNK activation, and in turn to augmented non-canonical
NLRP3 inflammasome activation. During C. rodentium infection
in vivo, this impaired initial bacterial colonization of the colon and
provided protection of the epithelium up to days 10 after infection.
However, in other colitis models, increased inflammasome
activation may result in increased damage to the colon tissue if
left unchecked. The NOD2-RIP2 pathway has been associated
with Crohn’s disease in humans [57] and plays an essential role in
several mouse models of colitis [58–62]. As Rip2-deficiency leads
to enhanced inflammasome activation, it will be of interest to
Figure 3. Increased mitochondrial damage in Rip22/2 cells drives enhanced inflammasome activation. WT and Rip22/2 BMDM were
infected with 20MOI of C. rodentium for 18 h. (A) Supernatants were collected and analyzed for IL-6 and TNF-a secretion. (B–D) WT-LC3-GFP and
Rip22/2-LC3-GFP BMDM were infected with 20MOI of C. rodentium and were examined for LC3+ autophagosomes (Arrows) at 18 h by confocal
microscopy (B–C) or LC3 geometric mean fluorescence intensity (MFI) at 4 h and 18 h by flow cytometry (D). (E–F) BMDM were stained with the
mitochondrial specific superoxide sensitive dye MitoSOX and analyzed by flow cytometry. (G–H)WT and Rip22/2 BMDM were infected with 20MOI of
C. rodentium for 2 h and Rip22/2 cells were subsequently treated with NAC or mock treated as a control. After 18 h, supernatant and lysates were
combined and examined by Western blot for caspase-1 cleavage (casp-1p20) visually (G) and by densitometry (H). (I) Supernatants were also
examined at 18 h after C. rodentium infection for IL-18 secretion. (A,E–I) Data are representative of three independent experiments with n = 2–4 wells
per experiment. (B–C) Data are representative of 2–3 independent experiments with n = 1–3 wells per experiment and displayed as the mean6 SEM.
(*, p,0.05; **, p,0.01; ***, p,0.001).
doi:10.1371/journal.ppat.1004410.g003
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examine caspase-1 activation in other models where inflammation
is a key factor and where the NOD2-RIP2 axis is involved.
Materials and Methods
Ethics statement
Experiments were conducted under protocols approved by the St.
Jude Children’s Research Hospital Committee on Use and Care of
Animals (Protocol #482) and were performed in accordance with
institutional policies, AAALAC guidelines, the AVMA Guidelines
on Euthanasia (CO2 asphyxiation followed by cervical dislocation),
NIH regulations (Guide for the Care and Use of Laboratory
Animals), and the United States Animal Welfare Act (1966).
Mice
All mice were maintained at SJCRH and were backcrossed for
at least 10 generations onto the C57BL/6J (B6) background.
Nod22/2, Rip22/2 and Rip22/26Il182/2 mice have been
reported previously [39,63,64]. WT-GFP-LC3+ and Rip22/2-
GFP-LC3+ mice were generated by crossing WT or Rip22/2 mice
with LysM-Cre+ Atg7loxP/loxP GFP-LC3+ mice [39] and selecting
progeny that only contained the GFP-LC3 transgene but not
LysM-Cre or Atg7loxP/loxP. All mice were housed in the SJCRH
animal resource center, which is a specific pathogen free (SPF) and
AAALAC accredited facility.
Bacterial infection, caspase-1 activation and IL-18
production
WT, Nod22/2 and Rip22/2 bone marrow derived macro-
phages (BMDM) were differentiated in complete IMDM contain-
ing 10% heat-inactivated FBS and supplemented with M-CSF
containing L929 supernatant at 37uC in a humidified atmosphere
containing 5% CO2 for 5 days. Citrobacter rodentium (ATCC
51459), Salmonella typhimurium (SL1344), Salmonella typhimur-
ium Dfljb/flic were grown in LB broth overnight with shaking at
37uC. Next day, the bacteria were subcultured to mid-log phase,
washed in PBS and BMDM were infected with 20 multiplicity of
infection (MOI) of C. rodentium, 1MOI of S. typhimurium, or
10MOI of S. typhimurium Dfljb/flic. Cell lysates combined with
supernatants were collected after 18 h of infection and assessed for
caspase-1 activation by Western blot using the anti-caspase-1 p20
antibody from Adipogen (AG-20B-0042-C100). Western blots
were imaged on a Kodak IMM4000pro and the densitometry
performed using the Carestream software provided by the
manufacturer. Caspase-1 p20 levels were normalized to the
proCaspase-1 for that lane. Supernatants collected at 18 h after
infection were analyzed for IL-6, TNF-a, or IL-18 by ELISA
according to the manufacturer’s instructions (eBiosciences) or for
type-I interferon by the RAW-Blue ISG cell line (Invivogen).
C. rodentium growth assay in BMDM
WT, Nod22/2 and Rip22/2 macrophages were grown in 24-
well plates and infected with 10 MOI of C. rodentium at 37uC.
After 2 h of infection, cells were washed three times with PBS and
10 mg/ml of gentamicin was added to kill extracellular bacteria.
Cells were lysed in 0.1% Triton X-100 at indicated times and
lysates were serially diluted and plated on LB agar plates. The
colonies were counted after 18 h of growth at 37uC
Treatments
For SP600125 (JNK inhibitor, 10 mM, Santa Cruz Biotechnol-
ogy), N-acetyl-L-cysteine (NAC, 10 mM, Sigma) or glyburide
(200 mM, Sigma) treatment, BMDMs were exposed to these
inhibitors after 2 h of C. rodentium infection. For H2O2 treatment,
BMDM were treated at 6 h after infection. For MG-132 (1 mM)
treatment, BMDM were treated at 4 h after infection, at 2, 4, 8 or
18 h after infection, supernatants were collected for ELISA and
cells or cells + supernatants were lysed with RIPA buffer
containing protease inhibitors and phosphatase inhibitors (Cal-
biochem), followed by boiling in sodium dodecyl sulfate (SDS)
sample buffer and examined by Western blot. Anti-caspase-1 p20
(Adipogen), anti-caspase-1 p10 (Santa Cruz Biotechnology, A20),
anti-total JNK (Cell signaling Technologies, 9252), anti-phospho
JNK (Cell signaling Technologies, 9251L) and anti-caspase-11
antibodies (Enzo, 4E11) were used for Western blot detection and
equal loading was verified by blotting with anti-GAPDH or anti-
Tubulin (Cell Signaling Technologies). HRP-labeled anti-mouse
or -rabbit antibodies were obtained from Jackson Immuno
Research. Caspase-11 densitometry was normalized to the
procaspase-11 level in the uninfected lane for each sample.
Phospho-JNK densitometry was normalized to GAPDH loading
control for each lane. IL-18 levels were determined in the
supernatants by ELISA according to manufacturer’s instructions
(eBioscience). Alternatively, cells were collected at the indicated
time points and RNA isolated for analysis by qRT-PCR. Primers:
GAPDH forward 59-CGTCCCGTAGACAAAATGGT-39 re-
verse 59-TTGATGGCAACAATCTCCAC-39; IL-18 forward 59-
GCCTCAAACCTTCCAAATCA-39 reverse 59-TGGATCCAT-
TTCCTCAAAGG-39; Caspase-11 forward 59-ACAATGCT-
GAACGCAGTGAC-39 reverse 59-CTGGTTCCTCCATTTC-
CAGA-39.
ROS production
For staining mitochondria, uninfected BMDMs were used as
controls or infected with 20MOI of C. rodentium for 18 h and
then stained for 30 min in fresh medium containing 5 mM
MitoSOX. Cells were then washed in HBSS, resuspended in flow
cytometry buffer (DPBS with 1% FBS and 0.04% NaN3) and
analyzed immediately by flow cytometry.
Autophagy
WT-GFP-LC3+ and Rip22/2-GFP-LC3+ mice were used to
generate BMDM as before and cells were infected with 20MOI of
C. rodentium for 4 h or 18 h. Cells were then permeabilized with
0.05% saponin in PBS for 5 min to remove cytosolic GFP-LC3
and cells were fixed in 4% paraformaldehyde in PBS for 5 min.
Figure 4. RIP2 regulates the caspase-11 non-canonical inflammasome. (A–B) WT and Rip22/2 BMDM were infected with 20MOI of C.
rodentium for 18 h and combined supernatant and lysates were examined by Western blot for caspase-11 cleavage (casp-11p30) visually (A) and by
densitometry (B). (C–D) WT and Rip22/2 BMDM were infected with 20MOI of C. rodentium for 2 h and Rip22/2 cells were subsequently treated with
NAC or mock treated as a control. Samples were collected at 18 h and caspase-11 activation was examined as in panels A–B. (E) Densitometry was
performed on pro-Caspase-11 p43 band from 3 independent experiments. (F–G) WT and Rip22/2 BMDM were infected with 20MOI of C. rodentium
for 4 h and cells were subsequently treated with 1 mM MG-132 or mock treated as a control. Samples were collected at the indicated time points and
pro-caspase-11 levels examined by Western blot and densitometry. (H) WT and Rip22/2 BMDM were infected with 20MOI of C. rodentium and RNA
collected at the indicated time points and analyzed by qRT-PCR for fold induction and normalized to GAPDH. (A–H) Data are representative of three
independent experiments with n = 2–3 wells per experiment and displayed as the mean 6 SEM. (**, p,0.01; ***, p,0.001).
doi:10.1371/journal.ppat.1004410.g004
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Figure 5. ROS enhances caspase-11 expression.WT BMDMwere infectedwith 20MOI of C. rodentium for 6 h andmock treated or treatedwith 50 mM
of H2O2 as a ROS source. (A) BMDM were collected at 8 h or 18 h after initial infection and examined for Il18mRNA expression by qRT-PCR. (B) Supernatants
were collected 18 h post-infection and IL-18 levels determined by ELISA. (C) WT BMDMs were examined by Western blot for caspase-1 activation. (D–F)
Caspase-11 expression was examined at the (D) mRNA level by qRT-PCR or the (E–F) protein level by Western blot and densitometric analysis. (A–F) Data are
representative of three independent experiments with n=2–4 wells per experiment and displayed as the mean 6 SD. (*, p,0.05; ***, p,0.001).
doi:10.1371/journal.ppat.1004410.g005
ROS Regulates Casp-11 Pathway
PLOS Pathogens | www.plospathogens.org 10 September 2014 | Volume 10 | Issue 9 | e1004410
Figure 6. RIP2 regulates caspases-11 expression through a ROS-JNK pathway. (A) WT and Rip22/2 BMDM were infected with 20MOI of C.
rodentium for 18 h and supernatants collected and examined for type-I interferon using a reporter cell line (U=Units). (B–C) WT or Rip22/2 BMDM
were infected with 20MOI of C. rodentium and mock treated or treated with H2O2. Samples were collected at the indicated times and examined for
total JNK or phosphorylated JNK by Western blot. (D) WT or Rip22/2 BMDM were infected with 20MOI of C. rodentium and mock treated or treated
with the JNK inhibitor SP600125 (JNKi). Samples were collected at the indicated times and examined for total JNK, phosphorylated JNK and caspase-
11 by western blot. (E) Proposed signaling pathway that regulates inflammasome activation. (A) Data are combined from 9 independent experiments
and displayed as the mean 6 SEM. (B–D) Data are representative of 3 independent experiments. (n.s. = not significant).
doi:10.1371/journal.ppat.1004410.g006
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Cells were then examined by fluorescence confocal microscopy for
the number of GFP-LC3+ puncta after staining with Alexafluor
647 phalloidin and mounting with ProLong Gold+DAPI (Life
Technologies). Alternatively, cell were scraped from wells and
resuspended in FACS buffer and examined by flow cytometry for
GFP intensity as a readout of autophagy.
Citrobacter rodentium induced colitis
Age and sex matched 8–10 week old mice were infected with
1010 CFU of C. rodentium by oral gavage. Stool was collected
from mice for CFU at the indicated time points. Mice were
euthanized on D10 and colons collected for CFU determination
by homogenizing in PBS or for Western blot by homogenizing in
RIPA buffer containing protease inhibitors and phosphatase
inhibitors (Calbiochem). Protein concentration was normalized
and samples analyzed by western blot; anti-IL-18 (MBL, 39-3F)
anti-caspase-1 p10 (Santa Cruz Biotechnology, A20) and anti-
caspase-11 antibodies (Enzo, 4E11) were used. Lysates were
additionally examined by ELISA for IL-18 (Ebiosciences) and
normalized to total protein. D10 colon samples were also
collected, formalin fixed and processed for routine histopatholog-
ical examination by hematoxylin and eosin staining. Sections were
examined by a board certified veterinary pathologist (Peter Vogel)
for inflammation, bacterial invasion of epithelial surface, and
distribution of inflammation.
Statistics
All statistical analyses were performed using GraphPad Prisim
6.0. Students t-Test was used for single comparisons and One-Way
ANOVA with Dunnett’s or Sidak’s post-hoc test for multiple
comparisons. Two-way ANOVA was used to analyze C.
rodentium growth between groups over time.
Acknowledgments
We thank Prajwal Gurung, John Lukens, and Si Ming Man for helpful
review of the manuscript. We also thank Richard Flavell (Yale University)
for the generous supply of mutant mice.
Author Contributions
Conceived and designed the experiments: CRL PKA ZL TDK. Performed
the experiments: CRL PKA ZL KLS PV. Analyzed the data: CRL PKA
ZL PV ML TDK. Contributed reagents/materials/analysis tools: TDK.
Contributed to the writing of the manuscript: CRL PKA ML TDK.
References
1. Kaper JB, Nataro JP, Mobley HL (2004) Pathogenic Escherichia coli. Nat Rev
Microbiol 2: 123–140.
2. Borenshtein D, McBee ME, Schauer DB (2008) Utility of the Citrobacter
rodentium infection model in laboratory mice. Curr Opin Gastroenterol 24: 32–
37.
3. Mundy R, MacDonald TT, Dougan G, Frankel G, Wiles S (2005) Citrobacter
rodentium of mice and man. Cell Microbiol 7: 1697–1706.
4. Kamada N, Kim YG, Sham HP, Vallance BA, Puente JL, et al. (2012)
Regulated virulence controls the ability of a pathogen to compete with the gut
microbiota. Science 336: 1325–1329.
5. Simmons CP, Clare S, Ghaem-Maghami M, Uren TK, Rankin J, et al. (2003)
Central role for B lymphocytes and CD4+ T cells in immunity to infection by the
attaching and effacing pathogen Citrobacter rodentium. Infect Immun 71:
5077–5086.
6. Bry L, Brenner MB (2004) Critical role of T cell-dependent serum antibody, but
not the gut-associated lymphoid tissue, for surviving acute mucosal infection with
Citrobacter rodentium, an attaching and effacing pathogen. J Immunol 172:
433–441.
7. Gibson DL, Ma C, Bergstrom KS, Huang JT, Man C, et al. (2008) MyD88
signalling plays a critical role in host defence by controlling pathogen burden
and promoting epithelial cell homeostasis during Citrobacter rodentium-induced
colitis. Cell Microbiol 10: 618–631.
8. Gibson DL, Ma C, Rosenberger CM, Bergstrom KS, Valdez Y, et al. (2008)
Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during
Citrobacter rodentium-induced colitis. Cell Microbiol 10: 388–403.
9. Kim YG, Kamada N, Shaw MH, Warner N, Chen GY, et al. (2011) The Nod2
sensor promotes intestinal pathogen eradication via the chemokine CCL2-
dependent recruitment of inflammatory monocytes. Immunity 34: 769–780.
10. Geddes K, Rubino SJ, Magalhaes JG, Streutker C, Le Bourhis L, et al. (2011)
Identification of an innate T helper type 17 response to intestinal bacterial
pathogens. Nat Med 17: 837–844.
11. Girardin SE, Tournebize R, Mavris M, Page AL, Li X, et al. (2001) CARD4/
Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri.
EMBO Rep 2: 736–742.
12. Bertin J, Nir WJ, Fischer CM, Tayber OV, Errada PR, et al. (1999) Human
CARD4 protein is a novel CED-4/Apaf-1 cell death family member that
activates NF-kappaB. J Biol Chem 274: 12955–12958.
13. Park JH, Kim YG, McDonald C, Kanneganti TD, Hasegawa M, et al. (2007)
RICK/RIP2 mediates innate immune responses induced through Nod1 and
Nod2 but not TLRs. J Immunol 178: 2380–2386.
14. Munoz-Planillo R, Kuffa P, Martinez-Colon G, Smith BL, Rajendiran TM,
et al. (2013) K(+) Efflux Is the Common Trigger of NLRP3 Inflammasome
Activation by Bacterial Toxins and Particulate Matter. Immunity 38: 1142–
1153.
15. Meixenberger K, Pache F, Eitel J, Schmeck B, Hippenstiel S, et al. (2010)
Listeria monocytogenes-infected human peripheral blood mononuclear cells
produce IL-1beta, depending on listeriolysin O and NLRP3. J Immunol 184:
922–930.
16. Witzenrath M, Pache F, Lorenz D, Koppe U, Gutbier B, et al. (2011) The
NLRP3 inflammasome is differentially activated by pneumolysin variants and
contributes to host defense in pneumococcal pneumonia. J Immunol 187: 434–
440.
17. Casson CN, Copenhaver AM, Zwack EE, Nguyen HT, Strowig T, et al. (2013)
Caspase-11 activation in response to bacterial secretion systems that access the
host cytosol. PLoS Pathog 9: e1003400.
18. Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, et al. (2009)
Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors
license NLRP3 inflammasome activation by regulating NLRP3 expression.
J Immunol 183: 787–791.
19. Lamkanfi M, Kanneganti TD (2010) Nlrp3: an immune sensor of cellular stress
and infection. Int J Biochem Cell Biol 42: 792–795.
20. Tschopp J, Schroder K (2010) NLRP3 inflammasome activation: The
convergence of multiple signalling pathways on ROS production? Nat Rev
Immunol 10: 210–215.
21. Kanneganti TD, Lamkanfi M, Nunez G (2007) Intracellular NOD-like receptors
in host defense and disease. Immunity 27: 549–559.
22. Kanneganti TD, Ozoren N, Body-Malapel M, Amer A, Park JH, et al. (2006)
Bacterial RNA and small antiviral compounds activate caspase-1 through
cryopyrin/Nalp3. Nature 440: 233–236.
23. Manji GA, Wang L, Geddes BJ, Brown M, Merriam S, et al. (2002) PYPAF1, a
PYRIN-containing Apaf1-like protein that assembles with ASC and regulates
activation of NF-kappa B. J Biol Chem 277: 11570–11575.
24. Fink SL, Cookson BT (2005) Apoptosis, pyroptosis, and necrosis: mechanistic
description of dead and dying eukaryotic cells. Infect Immun 73: 1907–1916.
Figure 7. Enhanced inflammasome activation results in protection in vivo.WT and Rip22/2 mice were infected with C. rodentium. On day 10
after infection, colon tissue lysates were prepared and analyzed by Western blot for (A) caspase-11, (B) caspase-1 and (C) IL-18. (D) IL-18 in colon
lysates was also examined by ELISA. (E) Colon homogenates were examined for C. rodentium colony forming units (CFU) on day 10 after infection. (F–
G) Colon tissue from WT and Rip22/2mice was fixed and H&E stained. (F) Arrows indicate adherent bacteria on the epithelial surface. (G) A veterinary
pathologist analyzed H&E stained sections for the indicated clinical scores. (H–I) Stool samples from C. rodentium infected mice were collected on the
indicated days (H) or day 7 (I) and analyzed for C. rodentium CFU. (A–H) Data are representative of two independent experiments with n = 6–9 mice
per genotype per experiment and displayed as the mean6 SEM. (I) Data are combined from 2 experiments and displayed as the mean6 SEM. (*, p,
0.05; **, p,0.01; ***, p,0.001).
doi:10.1371/journal.ppat.1004410.g007
ROS Regulates Casp-11 Pathway
PLOS Pathogens | www.plospathogens.org 13 September 2014 | Volume 10 | Issue 9 | e1004410
25. Miao EA, Leaf IA, Treuting PM, Mao DP, Dors M, et al. (2010) Caspase-1-
induced pyroptosis is an innate immune effector mechanism against intracellular
bacteria. Nat Immunol 11: 1136–1142.
26. Kayagaki N, Warming S, Lamkanfi M, Vande Walle L, Louie S, et al. (2011)
Non-canonical inflammasome activation targets caspase-11. Nature 479: 117–
121.
27. Wang S, Miura M, Jung YK, Zhu H, Li E, et al. (1998) Murine caspase-11, an
ICE-interacting protease, is essential for the activation of ICE. Cell 92: 501–509.
28. Case CL, Kohler LJ, Lima JB, Strowig T, de Zoete MR, et al. (2013) Caspase-11
stimulates rapid flagellin-independent pyroptosis in response to Legionella
pneumophila. Proc Natl Acad Sci U S A 110: 1851–1856.
29. Broz P, Ruby T, Belhocine K, Bouley DM, Kayagaki N, et al. (2012) Caspase-11
increases susceptibility to Salmonella infection in the absence of caspase-1.
Nature 490: 288–291.
30. Gurung P, Malireddi RK, Anand PK, Demon D, Walle LV, et al. (2012) Toll or
interleukin-1 receptor (TIR) domain-containing adaptor inducing interferon-
beta (TRIF)-mediated caspase-11 protease production integrates Toll-like
receptor 4 (TLR4) protein- and Nlrp3 inflammasome-mediated host defense
against enteropathogens. J Biol Chem 287: 34474–34483.
31. Rathinam VA, Vanaja SK, Waggoner L, Sokolovska A, Becker C, et al. (2012)
TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-
negative bacteria. Cell 150: 606–619.
32. Mariathasan S, Newton K, Monack DM, Vucic D, French DM, et al. (2004)
Differential activation of the inflammasome by caspase-1 adaptors ASC and
Ipaf. Nature 430: 213–218.
33. Martinon F, Burns K, Tschopp J (2002) The inflammasome: a molecular
platform triggering activation of inflammatory caspases and processing of proIL-
beta. Mol Cell 10: 417–426.
34. Franchi L, Amer A, Body-Malapel M, Kanneganti TD, Ozoren N, et al. (2006)
Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta
in salmonella-infected macrophages. Nat Immunol 7: 576–582.
35. Miao EA, Alpuche-Aranda CM, Dors M, Clark AE, Bader MW, et al. (2006)
Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via
Ipaf. Nat Immunol 7: 569–575.
36. Lamkanfi M, Mueller JL, Vitari AC, Misaghi S, Fedorova A, et al. (2009)
Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J Cell Biol 187: 61–70.
37. Nakahira K, Haspel JA, Rathinam VA, Lee SJ, Dolinay T, et al. (2011)
Autophagy proteins regulate innate immune responses by inhibiting the release
of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol
12: 222–230.
38. Zhou R, Yazdi AS, Menu P, Tschopp J (2011) A role for mitochondria in
NLRP3 inflammasome activation. Nature 469: 221–225.
39. Lupfer C, Thomas PG, Anand PK, Vogel P, Milasta S, et al. (2013) Receptor
interacting protein kinase 2-mediated mitophagy regulates inflammasome
activation during virus infection. Nat Immunol 14: 480–488.
40. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, et al. (2000) LC3,
a mammalian homologue of yeast Apg8p, is localized in autophagosome
membranes after processing. EMBO J 19: 5720–5728.
41. Lo YY, Wong JM, Cruz TF (1996) Reactive oxygen species mediate cytokine
activation of c-Jun NH2-terminal kinases. J Biol Chem 271: 15703–15707.
42. Yang S, Wang B, Humphries F, Jackson R, Healy ME, et al. (2013) Pellino3
ubiquitinates RIP2 and mediates Nod2-induced signaling and protective effects
in colitis. Nat Immunol 14: 927–936.
43. Meunier E, Dick MS, Dreier RF, Schurmann N, Kenzelmann Broz D, et al.
(2014) Caspase-11 activation requires lysis of pathogen-containing vacuoles by
IFN-induced GTPases. Nature 509: 366–370.
44. Aachoui Y, Leaf IA, Hagar JA, Fontana MF, Campos CG, et al. (2013) Caspase-
11 protects against bacteria that escape the vacuole. Science 339: 975–978.
45. Pilla DM, Hagar JA, Haldar AK, Mason AK, Degrandi D, et al. (2014)
Guanylate binding proteins promote caspase-11-dependent pyroptosis in
response to cytoplasmic LPS. Proc Natl Acad Sci U S A 111: 6046–6051.
46. Kayagaki N, Wong MT, Stowe IB, Ramani SR, Gonzalez LC, et al. (2013)
Noncanonical inflammasome activation by intracellular LPS independent of
TLR4. Science 341: 1246–1249.
47. Hagar JA, Powell DA, Aachoui Y, Ernst RK, Miao EA (2013) Cytoplasmic LPS
activates caspase-11: implications in TLR4-independent endotoxic shock.
Science 341: 1250–1253.
48. Liu Z, Zaki MH, Vogel P, Gurung P, Finlay BB, et al. (2012) Role of
inflammasomes in host defense against Citrobacter rodentium infection. J Biol
Chem 287: 16955–16964.
49. Akhter A, Caution K, Abu Khweek A, Tazi M, Abdulrahman BA, et al. (2012)
Caspase-11 promotes the fusion of phagosomes harboring pathogenic bacteria
with lysosomes by modulating actin polymerization. Immunity 37: 35–47.
50. Monack DM, Hersh D, Ghori N, Bouley D, Zychlinsky A, et al. (2000)
Salmonella exploits caspase-1 to colonize Peyer’s patches in a murine typhoid
model. J Exp Med 192: 249–258.
51. Kovarova M, Hesker PR, Jania L, Nguyen M, Snouwaert JN, et al. (2012)
NLRP1-dependent pyroptosis leads to acute lung injury and morbidity in mice.
J Immunol 189: 2006–2016.
52. Willingham SB, Allen IC, Bergstralh DT, Brickey WJ, Huang MT, et al. (2009)
NLRP3 (NALP3, Cryopyrin) facilitates in vivo caspase-1 activation, necrosis,
and HMGB1 release via inflammasome-dependent and -independent pathways.
J Immunol 183: 2008–2015.
53. Anand PK, Tait SW, Lamkanfi M, Amer AO, Nunez G, et al. (2011) TLR2 and
RIP2 pathways mediate autophagy of Listeria monocytogenes via extracellular
signal-regulated kinase (ERK) activation. J Biol Chem 286: 42981–42991.
54. Bertrand MJ, Doiron K, Labbe K, Korneluk RG, Barker PA, et al. (2009)
Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate
immunity signaling by the pattern recognition receptors NOD1 and NOD2.
Immunity 30: 789–801.
55. Mariathasan S, Weiss DS, Newton K, McBride J, O’Rourke K, et al. (2006)
Cryopyrin activates the inflammasome in response to toxins and ATP. Nature
440: 228–232.
56. Said-Sadier N, Padilla E, Langsley G, Ojcius DM (2010) Aspergillus fumigatus
stimulates the NLRP3 inflammasome through a pathway requiring ROS
production and the Syk tyrosine kinase. PLoS One 5: e10008.
57. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, et al. (2001)
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s
disease. Nature 411: 599–603.
58. Reingold L, Rahal K, Schmiedlin-Ren P, Rittershaus AC, Bender D, et al.
(2013) Development of a peptidoglycan-polysaccharide murine model of
Crohn’s disease: effect of genetic background. Inflamm Bowel Dis 19: 1238–
1244.
59. Jamontt J, Petit S, Clark N, Parkinson SJ, Smith P (2013) Nucleotide-binding
oligomerization domain 2 signaling promotes hyperresponsive macrophages and
colitis in IL-10-deficient mice. J Immunol 190: 2948–2958.
60. Couturier-Maillard A, Secher T, Rehman A, Normand S, De Arcangelis A, et
al. (2013) NOD2-mediated dysbiosis predisposes mice to transmissible colitis and
colorectal cancer. J Clin Invest 123: 700–711.
61. Watanabe T, Kitani A, Murray PJ, Wakatsuki Y, Fuss IJ, et al. (2006) Nucleotide
binding oligomerization domain 2 deficiency leads to dysregulated TLR2
signaling and induction of antigen-specific colitis. Immunity 25: 473–485.
62. Amendola A, Butera A, Sanchez M, Strober W, Boirivant M (2013) Nod2
deficiency is associated with an increased mucosal immunoregulatory response
to commensal microorganisms. Mucosal Immunol 7: 391–404.
63. Kobayashi K, Inohara N, Hernandez LD, Galan JE, Nunez G, et al. (2002)
RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and
adaptive immune systems. Nature 416: 194–199.
64. Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, Inohara N, et al. (2005)
Nod2-dependent regulation of innate and adaptive immunity in the intestinal
tract. Science 307: 731–734.
ROS Regulates Casp-11 Pathway
PLOS Pathogens | www.plospathogens.org 14 September 2014 | Volume 10 | Issue 9 | e1004410
